GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
0.689
0.00 (0.00%)
At close: Nov 22, 2024, 4:00 PM
0.680
-0.009 (-1.31%)
After-hours: Nov 22, 2024, 7:05 PM EST

GRI Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
4.328.1620.811.2
Research & Development
3.993.230.240.250.26
Other Operating Expenses
-0.25-0.25---
Operating Expenses
8.0611.142.241.061.46
Operating Income
-8.06-11.14-2.24-1.06-1.46
Interest Expense
-2.08-2.08-0.65-0.55-1.07
Other Non Operating Income (Expenses)
-0.230.18---
EBT Excluding Unusual Items
-8.26-13.04-2.89-1.61-2.53
Other Unusual Items
---0.330.05-
Pretax Income
-8.26-13.04-3.22-1.56-2.53
Net Income
-8.26-13.04-3.22-1.56-2.53
Net Income to Common
-8.26-13.04-3.22-1.56-2.53
Shares Outstanding (Basic)
10-00
Shares Outstanding (Diluted)
10-00
Shares Change (YoY)
4890.31%--2.26%-
EPS (Basic)
-7.90-367.19--5.94-9.86
EPS (Diluted)
-7.90-367.19--5.94-9.86
Free Cash Flow
-12.17-9-1.09-0.85-0.83
Free Cash Flow Per Share
-11.63-253.43--3.23-3.24
EBITDA
-8.05-11.13-2.24-1.06-1.46
D&A For EBITDA
00000
EBIT
-8.06-11.14-2.24-1.06-1.46
Source: S&P Capital IQ. Standard template. Financial Sources.